Allergist Bidzina Kulumbegov publishes information on the COVAX platform's next 2-year plan.
"COVAX plans for 2021-2022: mobilize approximately 1.8 billion doses of vaccine for 92 countries, allowing each country to meet 27% of its population with sufficient vaccines.
Candidates for vaccines are AstraZeneca, Novavax - Serum Institute of India, AstraZeneca - non-Indian, Pfizer, J&J, Sanofi, and GSK...
P.S. "Let's pray for Covax," the doctor wrote.